MedPath

Focale

Brand Name: Focale

Generic Name: Levetiracetam

Active
Registration Number

DRP-12365

Dosage Form

Concentrate for Solution for IV Infusion

Issuance Date

January 17, 2023

Expiry Date

July 26, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength500 mg / 5 mL
PackagingType I Clear Glass Vial with bromobutyl rubber stopper and aluminum flip-off cap x 5 mL (Box of 10's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antiepileptic
A
Application
Initial (Correction)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

LevetiracetamActive
Monograph: Levetiracetam

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform